Found: 14
Select item for more details and to access through your institution.
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 151, doi. 10.1007/s00280-021-04381-4
- By:
- Publication type:
- Article
Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 209, doi. 10.1007/s00280-021-04371-6
- By:
- Publication type:
- Article
Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 217, doi. 10.1007/s00280-021-04392-1
- By:
- Publication type:
- Article
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 231, doi. 10.1007/s00280-021-04388-x
- By:
- Publication type:
- Article
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 243, doi. 10.1007/s00280-021-04385-0
- By:
- Publication type:
- Article
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 255, doi. 10.1007/s00280-021-04384-1
- By:
- Publication type:
- Article
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Lost in third space: altered tyrosine-kinase inhibitor pharmacokinetics in a patient with malignant ascites.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 275, doi. 10.1007/s00280-021-04382-3
- By:
- Publication type:
- Article
Correction to: Anticancer potential of metformin: focusing on gastrointestinal cancers.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice